Iptacopan

Iptacopan is a first-in-class, oral small-molecule factor B inhibitor that targets the alternative complement pathway. It binds to complement factor B, preventing the formation of C3 convertase, which stops C3b-mediated extravascular hemolysis and downstream C5-mediated intravascular hemolysis, effectively treating diseases like paroxysmal nocturnal hemoglobinuria (PNH). The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Fabhalta and Iptacopanum. Its PubChem CID is 90467622.

CAS No 1644670-37-0
Molecular Formula C25H30N2O4
Molecular Weight 422.5 g/mol
Synonyms 4-[(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl]benzoic acid

Frequently Asked Questions